X-Chem | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

---

X-Chem is a leading biotechnology research company specializing in small molecule drug discovery. Utilizing DNA-encoded chemical library (DEL) technology, discovery chemistry, and artificial intelligence, X-Chem provides comprehensive solutions for pharmaceutical and biotech companies. With a high success rate in identifying functional hits and a proven track record in various therapeutic targets, X-Chem is dedicated to advancing human health through innovative drug discovery services.

🛍️ X-Chem Product and Pricing News →

👔 X-Chem CEO, Management and Leadership Team →

⚔️ X-Chem Alternatives and Competitors →

💼 X-Chem Hiring and Layoffs →

🤖 X-Chem Developer, Integration and Automation News →

📈 X-Chem Financials, Fundraising and Valuation News →

---

🛍️ X-Chem Product and Pricing News

• X-Chem has replaced its ArtemisAI platform with Integrated Computational Sciences and introduced HITMiner to enhance DEL data analysis.
• Dr. Matthew Macauley, a GlycoNet Investigator and University of Alberta professor, received the X-Chem Research Excellence Award for 2025.
• In 2024, X-Chem advanced drug discovery with 12 peer-reviewed publications and breakthroughs in synthetic chemistry, covalent drug discovery, and DNA-Encoded Library screening.

---

👔 X-Chem CEO, Management and Leadership Team

• Karen Lackey

  
  Chief Executive Officer
  [email protected]

• Erin Davis

  
  Chief Technology Officer
  [email protected]

• David Hagerman

  
  Chief Financial Officer
  [email protected]

---

⚔️ X-Chem Alternatives and Competitors

• KBP Biosciences
|
• 10xBio
|
• TRIM-edicine
|
• Astex Pharmaceuticals
|
• Icagen
|
• TorreyPines Therapeutics
|
• Arrakis Therapeutics
|
• Atomwise
|
• Enveda Biosciences
|
• Exscientia
|
• Black Diamond Therapeutics
|
• Frontier Medicines
|
• Nurix Therapeutics
|
• Nimbus Therapeutics
|
• 1859
|
• Syngens AS
|
• STRmix
|
• Ventus Therapeutics
|
• Editas Medicine
|
• Domainex
|
• PhenoVista Biosciences
|
• Horizon Discovery
|
• Active Biotech

---

💼 X-Chem Hiring and Layoffs

• Lisa Lambertsen Yoder has joined X-Chem as Director of Marketing in the United States, previously holding a position at another company.
• X-Chem is currently seeking a Director of Accounting & Finance in the United States.
• Calum Hand has left X-Chem, where he was a Consultant Research Scientist in the United Kingdom, to join Apheris as a Senior ML Field Engineer.
• Tatiana Demidova-Rice has joined X-Chem as Senior Director of Business Development.
• Waseem Abbas has left X-Chem as a Machine Learning Engineer in the United Kingdom to join GSK as a Software Engineer AI/ML.

---

🤖 X-Chem Developer, Integration and Automation News

• X-Chem is collaborating with Tonix Pharma on the development of the antiviral drug TNX-4200 under a Department of Defense contract worth up to $34 million.

---

📈 X-Chem Financials, Fundraising and Valuation News

---

People also viewed

• HUMAN
|
• Feedzai
|
• molecule.one
|
• Time Doctor
|
• Hubstaff
|
• Clockify
|
• Sensaria